Industry: Medical Technology / Life Sciences
Company Size: Independent content and film production company
Region: Europe, globally oriented
Objective: Building a robust sponsorship and sales model for a physician-led documentary format
Key Results at a Glance
- Relevance with leading industry partners in a short period of time
- Healthy project pipeline with well-known MedTech companies
- Scalable sales model instead of isolated, opportunistic deals
Initial Situation
The documentary format was strong in content and medically credible – but not economically secured.
- Strong physician-led perspective and high cinematic quality
- First KOLs involved, but no systematic monetization
- Sales heavily founder-driven and not reproducible
- Without structure, the format risked remaining a passion project, regardless of quality
Challenge
The core challenge was not reach, but economic viability in a MedTech context.
- Uncertainty whether and how MedTech companies would accept the format as a sponsorship platform
- No structured access to KOLs and industry decision-makers
- Lack of a clear sponsorship narrative beyond traditional advertising
- Unclear separation between medical credibility and commercial interests
- High operational burden on the founders due to missing processes
Solution & Approach
The goal was not another strategy paper, but a functioning business and sales model that could prove itself in the market.
- Market and viability analysis of product, target groups, and scalability
- Clear positioning as a credible communication platform for innovative MedTech companies
- Target group architecture with KOLs as trust anchors and door openers
- Structured sponsorship logic with clear value propositions
- Design of a reproducible sales and funnel system
- Ongoing role as an extended business development and sales unit
From the start, the focus was on reproducibility and scalability – not one-off solutions.
Results & Evidence
Within a short time, the format evolved from a content-driven initiative into a commercially validated model.
- Collaboration with leading MedTech companies as clear market validation
- Rapidly growing, qualified project pipeline
- Structurally mapped sales cycles ranging from immediate decisions to 12–18 month project timelines
- Clearly defined growth path toward a seven-figure revenue target
Additional long-term effects:
- Clear positioning with MedTech decision-makers
- Structured, repeatable access to KOLs
- Significant relief for the founders
- A scalable and reproducible sales process
You have a complex MedTech product or format, but no scalable access to decision-makers or KOLs?
→ Let’s assess whether a structured content and sales approach makes economic sense for your growth.